Tag: exposure-response

Visualizing PK/PD and Exposure-Response for Non-Statisticians Visualizing PK/PD and Exposure-Response for Non-Statisticians In the realm of clinical trials, understanding pharmacokinetics (PK), pharmacodynamics (PD), and exposure-response relationships is paramount. This tutorial aims to equip clinical operations, regulatory affairs, and medical affairs professionals with essential knowledge for visualizing and interpreting PK/PD data, particularly for individuals without a…

Read More “Visualizing PK/PD and Exposure-Response for Non-Statisticians” »

PK/PD and Exposure-Response Modeling in Clinical Development Strategy PK/PD and Exposure-Response Modeling in Clinical Development Strategy The complex landscape of clinical development necessitates robust methodologies to ensure the safety and efficacy of new therapies. Pharmacokinetics (PK) and Pharmacodynamics (PD), combined with exposure-response modeling, offer strategic frameworks for understanding drug behavior and response. This step-by-step tutorial…

Read More “PK/PD and Exposure-Response Modeling in Clinical Development Strategy” »

Designing PK/PD Substudies Within Phase I–III Clinical Trials The design of pharmacokinetic (PK) and pharmacodynamic (PD) substudies is crucial for the successful conduct of clinical trials across Phases I to III. Understanding the intricate relationships between drug exposure and response enables clinical research organizations (CROs) to maximize the therapeutic potential of new treatments while ensuring…

Read More “Designing PK/PD Substudies Within Phase I–III Clinical Trials” »

Population PK Modeling: Data Requirements, Methods and Tools Population PK Modeling: Data Requirements, Methods and Tools Population pharmacokinetics (PK) modeling is a critical component of drug development, particularly relevant for biosimilar clinical trials and other therapeutic areas like til therapy clinical trials. This comprehensive guide serves to inform clinical operations, regulatory affairs, and medical affairs…

Read More “Population PK Modeling: Data Requirements, Methods and Tools” »

Exposure-Response Analyses to Support Dose Selection and Labeling Exposure-Response Analyses to Support Dose Selection and Labeling Introduction to Exposure-Response Analyses in Clinical Trials Exposure-response (E-R) analyses are critical components of drug development, providing essential insights that facilitate dose selection and labeling for new therapeutics. These analyses evaluate the relationship between drug exposure—often quantified by metrics…

Read More “Exposure-Response Analyses to Support Dose Selection and Labeling” »